These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2495599)

  • 1. Effect of HLA class II antigen in in vitro and in vivo cellular responses.
    Matsuno N; Sano N; Nakatsuji T; Ando A; Inoko H; Tsuji K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):158-9. PubMed ID: 2495599
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon stimulation with murine L cells transfected with class I genes.
    Golding H; Bluestone J; Satz ML; Singer D; Singer A
    J Immunol; 1985 Jun; 134(6):3557-9. PubMed ID: 2580888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional roles of three distinct HLA class II molecules expressed by a gene-transfer technique.
    Nezu N; Koide Y; Ryu K; Yoshida TO
    Transplant Proc; 1990 Oct; 22(5):2345-51. PubMed ID: 2120818
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of murine class II major histocompatibility complex genes.
    Germain RN; Braunstein NS; Brown MA; Glimcher LH; Lechler RI; McCluskey J; Margulies DH; Miller J; Norcross MA; Paul WE
    Mt Sinai J Med; 1986 Mar; 53(3):194-201. PubMed ID: 3084960
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL; Bryde SE; Lipsky PE
    J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
    Hess AD; Thoburn CJ; Chen W; Bright AE
    Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
    Thoburn CJ; Miura Y; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    Mohler KM; Streilein JW
    J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immunological unresponsiveness using recipient cells transfected with donor class I or class II MHC genes.
    Madsen JC; Wood KJ; Superina RA; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):477. PubMed ID: 2495614
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen presenting function of class II MHC expressing pancreatic beta cells.
    Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
    Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.
    Bryson JS; Jennings CD; Lowery DM; Carlson SL; Pflugh DL; Caywood BE; Kaplan AM
    Bone Marrow Transplant; 1999 Feb; 23(4):363-72. PubMed ID: 10100580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived macrophage expression of endogenous and transfected class II MHC genes during differentiation in vitro.
    Pullen JK; Schook LB
    J Immunol; 1986 Aug; 137(4):1359-65. PubMed ID: 3090147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD4 domain 1 CC' loop peptide analogue enhances engraftment in a murine model of bone marrow transplantation with sublethal conditioning.
    Varadi G; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):979-87. PubMed ID: 16338620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ia-positive donor-specific bone marrow cells prolong renal allografts in dogs treated with fractionated lymphoid irradiation.
    Watanabe K; Taniai S; Sato K; Sonoda K; Masaki Y; Takahara H; Matsubayashi T; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):632-4. PubMed ID: 2978927
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.